Familial hypercholesterolemia in Asian populations

Journal of Atherosclerosis and Thrombosis

Volumn 23, Issue 5, 2016, Pages 539-549

  Zhou, Mengge ^a   Zhao, Dong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Asian population; Epidemiology; Familial hypercholesterolemia

Indexed keywords

APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; PCSK9 PROTEIN, HUMAN; PROPROTEIN CONVERTASE 9;

ASIAN; CHOLESTEROL BLOOD LEVEL; DISEASE REGISTRY; FAMILIAL HYPERCHOLESTEROLEMIA; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; MORBIDITY; PRACTICE GUIDELINE; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW (TOPIC); ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; HYPERLIPOPROTEINEMIA TYPE II; JAPAN; LEBANON; MUTATION; SOUTH KOREA; TAIWAN;

ALLELES; APOLIPOPROTEINS B; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; JAPAN; LEBANON; MUTATION; PROPROTEIN CONVERTASE 9; RECEPTORS, LDL; REPUBLIC OF KOREA; TAIWAN;

EID: 84964709317     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.34405     Document Type: Review

References (67)

1. Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, Brown WV, Bruckert E, Defesche J, Lin KK, Livingston M, Mata P, Parhofer KG, Raal FJ, Santos RD, Sijbrands EJ, Simpson WG, Sullivan DR, Susekov AV, Tomlinson B, Wiegman A, Yamashita S, Kastelein JJ: Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation. J Clin Lipidol, 2014; 8: 148-172
2. Brown MS, Goldstein JL: A receptor-mediated pathway for cholesterol homeostasis. Science, 1986; 232: 34-47
3. Innerarity TL, Weisgraber KH, Arnold KS, Mahley RW, Krauss RM, Vega GL, Grundy SM: Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. Proc Natl Acad Sci U S A, 1987; 84: 6919-6923
4. Abifadel M, Varret M, Rabes JP, Allard D, Ouguerram K, Devillers M, Cruaud C, Benjannet S, Wickham L, Erlich D, Derre A, Villeger L, Farnier M, Beucler I, Bruckert E, Chambaz J, Chanu B, Lecerf JM, Luc G, Moulin P, Weissenbach J, Prat A, Krempf M, Junien C, Seidah NG, Boileau C: Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet, 2003; 34: 154-156
5. Garcia CK, Wilund K, Arca M, Zuliani G, Fellin R, Maioli M, Calandra S, Bertolini S, Cossu F, Grishin N, Barnes R, Cohen JC, Hobbs HH: Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science, 2001; 292: 1394-1398
6. Liyanage KE, Burnett JR, Hooper AJ, van Bockxmeer FM: Familial hypercholesterolemia: epidemiology, Neolithic origins and modern geographic distribution. Crit Rev Clin Lab Sci, 2011; 48: 1-18
7. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG: Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest, 1973; 52: 1544-1568
8. Patterson D, Slack J: Lipid abnormalities in male and female survivors of myocardial infarction and their firstdegree relatives. The Lancet, 1972; 299: 393-399
9. Heiberg A, Berg K: The inheritance of hyperlipoprotein aemia with xanthomatosis. A study of 132 kindreds. Clin Genet, 1976; 9: 203-233
10. Kalina A, Csaszar A, Czeizel AE, Romics L, Szaboki F, Szalai C, Reiber I, Nemeth A, Stephenson S, Williams RR: Frequency of the R3500Q mutation of the apolipoprotein B-100 gene in a sample screened clinically for familial hypercholesterolemia in Hungary. Atherosclerosis, 2001; 154: 247-251
11. Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG: Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab, 2012; 97: 3956-3964
12. Sjouke B, Kusters DM, Kindt I, Besseling J, Defesche JC, Sijbrands EJ, Roeters van Lennep JE, Stalenhoef AF, Wiegman A, de Graaf J, Fouchier SW, Kastelein JJ, Hovingh GK: Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome. Eur Heart J, 2015; 36: 560-565
13. Rubinsztein DC, van der Westhuyzen DR, Coetzee GA: Monogenic primary hypercholesterolaemia in South Africa. S Afr Med J, 1994; 84: 339-344
14. Slimane MN, Pousse H, Maatoug F, Hammami M, Ben FM: Phenotypic expression of familial hypercholesterolaemia in central and southern Tunisia. Atherosclerosis, 1993; 104: 153-158
15. Kontula K, Koivisto UM, Koivisto P, Turtola H: Molecular genetics of familial hypercholesterolaemia: common and rare mutations of the low density lipoprotein receptor gene. Ann Med, 1992; 24: 363-367
16. Leitersdorf E, Van der Westhuyzen DR, Coetzee GA, Hobbs HH: Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners. J Clin Invest, 1989; 84: 954-961
17. Seftel HC, Baker SG, Jenkins T, Mendelsohn D: Prevalence of familial hypercholesterolemia in Johannesburg Jews. Am J Med Genet, 1989; 34: 545-547
18. Seftel HC, Baker SG, Sandler MP, Forman MB, Joffe BI, Mendelsohn D, Jenkins T, Mieny CJ: A host of hypercholesterolaemic homozygotes in South Africa. Br Med J, 1980; 281: 633-636
19. Moorjani S, Roy M, Gagne C, Davignon J, Brun D, Toussaint M, Lambert M, Campeau L, Blaichman S, Lupien P: Homozygous familial hypercholesterolemia among French Canadians in Québec province. Arterioscler Thromb Vasc Biol, 1989; 9: 211-216
20. WHO: Familial Hypercholesterolaemia (FH): report of a second WHO consultation, Geneva, 4 September 1998, World Health Organization, Human Genetics Program, 1999
21. WHO: Global health observatory data repository. Risk factors cholesterol. 2015
22. Mabuchi H, Haba T, Ueda K, Ueda R, Tatami R, Ito S, Kametani T, Koizumi J, Miyamoto S, Ohta M, Takeda R, Takegoshi T, Takeshita H: Serum lipids and coronary heart disease in heterozygous familial hypercholesterolemia in the Hokuriku District of Japan. Atherosclerosis, 1977; 28: 417-423
23. Slack J: Inheritance of familial hypercholesterolemia. Ath eroscler Rev, 1979; 5: 35-66
24. Austin MA, Hutter CM, Zimmern RL, Humphries SE: Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol, 2004; 160: 407-420
25. Mabuchi H, Nohara A, Noguchi T, Kobayashi J, Kawashiri M-a, Tada H, Nakanishi C, Mori M, Yamagishi M, Inazu A, Koizumi J: Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan. Atherosclerosis, 2011; 214: 404-407
26. Shi Z, Yuan B, Zhao D, Taylor AW, Lin J, Watts GF: Familial hypercholesterolemia in China: prevalence and evidence of underdetection and undertreatment in a community population. Int J Cardiol, 2014; 174: 834-836
27. Williams RR, Hunt SC, Schumacher MC, Hegele RA, Leppert MF, Ludwig EH, Hopkins PN: Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am J Cardiol, 1993; 72: 171-176
28. Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. BMJ, 1991; 303: 893-896
29. Xiao G, Chun-Mei W, Lv-Ya W: [The New Progress of Clinical Diagnosis and Treatment for Familial Hypercholesterolaemia and Dyslipidaemias]. Chinese Journal of Arteriosclerosis, 2014; 22: 525-528
30. Harada-Shiba M, Arai H, Okamura T, Yokote K, Oikawa S, Nohara A, Okada T, Ohta T, Bujo H, Watanabe M, Wakatsuki A, Yamashita S: Multicenter study to determine the diagnosis criteria of heterozygous familial hypercholesterolemia in Japan. J Atheroscler Thromb, 2012; 19: 1019-1026
31. Harada-Shiba M, Arai H, Oikawa S, Ohta T, Okada T, Okamura T, Nohara A, Bujo H, Yokote K, Wakatsuki A, Ishibashi S, Yamashita S: Guidelines for the management of familial hypercholesterolemia. J Atheroscler Thromb, 2012; 19: 1043-1060
32. Shin DG, Han SM, Kim DI, Rhee MY, Lee BK, Ahn YK, Cho BR, Woo JT, Hur SH, Jeong JO, Jang Y, Lee JH, Lee SH: Clinical features of familial hypercholesterolemia in Korea: Predictors of pathogenic mutations and coronary artery disease-A study supported by the Korean Society of Lipidology and Atherosclerosis. Atherosclerosis, 2015; 243: 53-58
33. Chiou KR, Charng MJ: Common mutations of familial hypercholesterolemia patients in Taiwan: characteristics and implications of migrations from southeast China. Gene, 2012; 498: 100-106
34. Chiou KR, Charng MJ: Detection of mutations and large rearrangements of the low-density lipoprotein receptor gene in Taiwanese patients with familial hypercholesterolemia. Am J Cardiol, 2010; 105: 1752-1758
35. Chiu CY, Wu YC, Jenq SF, Jap TS: Mutations in lowdensity lipoprotein receptor gene as a cause of hypercholesterolemia in Taiwan. Metabolism, 2005; 54: 1082-1086
36. Fan LL, Lin MJ, Chen YQ, Huang H, Peng DQ, Xia K, Zhao SP, Xiang R: Novel mutations of low-density lipoprotein receptor gene in China patients with familial hypercholesterolemia. Appl Biochem Biotechnol, 2015; 176: 101-109
37. Dai YF, Sun LY, Zhang XB, Wang LY: [Research progression of LDLR mutations in Chinese Familial hypercholesterolemia]. Yi Chuan, 2011; 33: 1-8
38. Mabuchi H, Nohara A, Noguchi T, Kobayashi J, Kawashiri MA, Inoue T, Mori M, Tada H, Nakanishi C, Yagi K, Yamagishi M, Ueda K, Takegoshi T, Miyamoto S, Inazu A, Koizumi J, Hokuriku FHSG: Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation. Atherosclerosis, 2014; 236: 54-61
39. Al-Khateeb A, Al-Talib H, Mohamed MS, Yusof Z, Zilfalil BA: Phenotype-genotype analyses of clinically diagnosed Malaysian familial hypercholestrolemic patients. Adv Clin Exp Med, 2013; 22: 57-67
40. Sozen MM, Whittall R, Oner C, Tokatli A, Kalkanoglu HS, Dursun A, Coskun T, Oner R, Humphries SE: The molecular basis of familial hypercholesterolaemia in Turkish patients. Atherosclerosis, 2005; 180: 63-71
41. Farrokhi E, Shayesteh F, Asadi Mobarakeh S, Roghani Dehkordi F, Ghatreh Samani K, Hashemzadeh Chaleshtori M: Molecular characterization of Iranian patients with possible familial hypercholesterolemia. Indian J Clin Biochem, 2011; 26: 244-248
42. Livy A, Lye SH: Familial hypercholesterolemia in Asia: a review. Journal of OMICS Research, 2011; 1: 22-31
43. Bamimore MA, Zaid A, Banerjee Y, Al-Sarraf A, Abifadel M, Seidah NG, Al-Waili K, Al-Rasadi K, Awan Z: Familial hypercholesterolemia mutations in the Middle Eastern and North African region: a need for a national registry. J Clin Lipidol, 2015; 9: 187-194
44. Joint Committee for Developing Chinese guidelines on P and Treatment of Dyslipidemia in A: [Chinese guidelines on prevention and treatment of dyslipidemia in adults]. Zhonghua Xin Xue Guan Bing Za Zhi, 2007; 35: 390-419
45. Son J-I, Chin SO, Woo J-T: Treatment guidelines for dyslipidemia: summary of the expanded second version. Journal of Lipid and Atherosclerosis, 2012; 1: 45-59
46. Pang J, Sullivan DR, Harada-Shiba M, Ding PY, Selvey S, Ali S, Watts GF: Significant gaps in awareness of familial hypercholesterolemia among physicians in selected Asia-Pacific countries: a pilot study. J Clin Lipidol, 2015; 9: 42-48
47. Vallejo-Vaz AJ, Kondapally Seshasai SR, Cole D, Hovingh GK, Kastelein JJ, Mata P, Raal FJ, Santos RD, Soran H, Watts GF, Abifadel M, Aguilar-Salinas CA, Akram A, Alnouri F, Alonso R, Al-Rasadi K, Banach M, Bogsrud MP, Bourbon M, Bruckert E, Car J, Corral P, Descamps O, Dieplinger H, Durst R, Freiberger T, Gaspar IM, Genest J, Harada-Shiba M, Jiang L, Kayikcioglu M, Lam CS, Latkovskis G, Laufs U, Liberopoulos E, Nilsson L, Nordestgaard BG, O'Donoghue JM, Sahebkar A, Schunkert H, Shehab A, Stoll M, Su TC, Susekov A, Widen E, Catapano AL, Ray KK: Familial hypercholesterolaemia: A global call to arms. Atherosclerosis, 2015; 243: 257-259
48. Hu M, Lan W, Lam CW, Mak YT, Pang CP, Tomlinson B: Heterozygous familial hypercholesterolemia in Hong Kong Chinese. Study of 252 cases. Int J Cardiol, 2013; 167: 762-767
49. Xenophontos SL, Pierides A, Demetriou K, Avraamides P, Manoli P, Ayrton N, Skordis N, Anastasiadou V, Miltiadous G, Cariolou MA: Geographical clustering of low density lipoprotein receptor gene mutations (C292X; Q363X; D365E & C660X) in Cyprus. Hum Mutat, 2000; 15: 380
50. Setia N, Verma IC, Khan B, Arora A: Premature coronary artery disease and familial hypercholesterolemia: need for early diagnosis and cascade screening in the Indian population. Cardiol Res Pract, 2012; 2012: 658526
51. Kondkar AA, Nair KG, Ashavaid TF: Genetic analysis of Indian subjects with clinical features of possible type IIa hypercholesterolemia. J Clin Lab Anal, 2007; 21: 375-381
52. Reshef A, Nissen H, Triger L, Hensen TS, Eliav O, Schurr D, Safadi R, Gare M, Leitersdorf E: Molecular genetics of familial hypercholesterolemia in Israel. Hum Genet, 1996; 98: 581-586
53. Miyake Y, Yamamura T, Sakai N, Miyata T, Kokubo Y, Yamamoto A: Update of Japanese common LDLR gene mutations and their phenotypes: Mild type mutation L547V might predominate in the Japanese population. Atherosclerosis, 2009; 203: 153-160
54. Yamashita S, Hbujo H, Arai H, Harada-Shiba M, Matsui S, Fukushima M, Saito Y, Kita T, Matsuzawa Y: Longterm probucol treatment prevents secondary cardiovascular events: a cohort study of patients with heterozygous familial hypercholesterolemia in Japan. J Atheroscler Thromb, 2008; 15: 292-303
55. Yu W, Nohara A, Higashikata T, Lu H, Inazu A, Mabuchi H: Molecular genetic analysis of familial hypercholesterolemia: spectrum and regional difference of LDL receptor gene mutations in Japanese population. Atherosclerosis, 2002; 165: 335-342
56. Kim JH, Choi HK, Lee H, Park HY, Kim JH, Kim JW, Kim HJ, Lee ST: Novel and recurrent mutations of the LDL receptor gene in Korean patients with familial hypercholesterolemia. Mol Cells, 2004; 18: 63-70
57. Shin JA, Kim SH, Kim UK, Chae JJ, Choe SJ, Namkoong Y, Kim HS, Park YB, Lee CC: Identification of four novel mutations of the low-density lipoprotein receptor gene in Korean patients with familial hypercholesterolemia. Clin Genet, 2000; 57: 225-229
58. Fahed AC, Safa RM, Haddad FF, Bitar FF, Andary RR, Arabi MT, Azar ST, Nemer G: Homozygous familial hypercholesterolemia in Lebanon: a genotype/phenotype correlation. Mol Genet Metab, 2011; 102: 181-188
59. Abifadel M, Rabes JP, Jambart S, Halaby G, Gannage-Yared MH, Sarkis A, Beaino G, Varret M, Salem N, Corbani S, Aydenian H, Junien C, Munnich A, Boileau C: The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene. Hum Mutat, 2009; 30: E682-691
60. Al-Khateeb AR, Mohd MS, Yusof Z, Zilfalil BA: Molecular description of familial defective APOB-100 in Malaysia. Biochem Genet, 2013; 51: 811-823
61. Lye SH, Chahil JK, Bagali P, Alex L, Vadivelu J, Ahmad WA, Chan SP, Thong MK, Zain SM, Mohamed R: Genetic polymorphisms in LDLR, APOB, PCSK9 and other lipid related genes associated with familial hypercholesterolemia in Malaysia. PLoS One, 2013; 8: e60729
62. Al-Khateeb A, Zahri MK, Mohamed MS, Sasongko TH, Ibrahim S, Yusof Z, Zilfalil BA: Analysis of sequence variations in low-density lipoprotein receptor gene among Malaysian patients with familial hypercholesterolemia. BMC Med Genet, 2011; 12: 40
63. Ahmed W, Whittall R, Riaz M, Ajmal M, Sadeque A, Ayub H, Qamar R, Humphries SE: The genetic spectrum of familial hypercholesterolemia in Pakistan. Clin Chim Acta, 2013; 421: 219-225
64. Ahmed W, Ajmal M, Sadeque A, Whittall RA, Rafiq S, Putt W, Khawaja A, Imtiaz F, Ahmed N, Azam M, Humphries SE, Qamar R: Novel and recurrent LDLR gene mutations in Pakistani hypercholesterolemia patients. Mol Biol Rep, 2012; 39: 7365-7372
65. Punzalan FE, Sy RG, Santos RS, Cutiongco EM, Gosiengfiao S, Fadriguilan E, George P, Laurie A: Low density lipoprotein--receptor (LDL-R) gene mutations among Filipinos with familial hypercholesterolemia. J Atheroscler Thromb, 2005; 12: 276-283
66. Alharbi KK, Kashour TS, Al-Hussaini W, Nbaheen MS, Hasanato RM, Mohamed S, Tamimi W, Khan IA: Screening for genetic mutations in LDLR gene with familial hypercholesterolemia patients in the Saudi population. Acta biochimica Polonica, 2015; 62: 559-562
67. Yudi M, Omera L, McCubbery N, Dick S, Jayasinghe R, Hamilton-Craig I: Suboptimal consideration and management of potential familial hypercholesterolaemia in patients with suspected premature coronary artery disease. Singapore Med J, 2012; 53: 174-178